QQ客服 官方微博 反馈留言

	Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial
	Gan, Jing; Wu, Yansheng; Gong, Xuezhong; Ma, Yiyi; Yu, Shengqiang; Gao, Jiandong
刊名	TRIALS
	2019
卷号	20期号:1
关键词	Yinang formulation Efficacy Safety Autosomal dominant polycystic kidney disease Stages III-IV chronic kidney disease Randomized controlled trial
ISSN号	1745-6215
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3631253
专题	上海中医药大学
推荐引用方式 GB/T 7714	Gan, Jing,Wu, Yansheng,Gong, Xuezhong,et al. Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial[J]. TRIALS,2019,20(1).
APA	Gan, Jing,Wu, Yansheng,Gong, Xuezhong,Ma, Yiyi,Yu, Shengqiang,&Gao, Jiandong.(2019).Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial.TRIALS,20(1).
MLA	Gan, Jing,et al."Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III-IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial".TRIALS 20.1(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。